Expression and characterization of a human BMP-7 variant with improved biochemical properties
- PMID: 17977014
- DOI: 10.1016/j.pep.2007.09.016
Expression and characterization of a human BMP-7 variant with improved biochemical properties
Abstract
Bone morphogenetic protein-7 (BMP-7, OP-1) is a secreted growth factor that is predominantly known for its osteoinductive properties, though it has also been implicated as having a role in mammalian kidney development. Clinical efficacy of recombinant BMP-7 has been demonstrated in the treatment of orthopedic injuries through topical application. However, the pharmaceutical development of recombinant BMP-7 for systemic delivery has presented many challenges. Specifically, the expression level of recombinant mature BMP-7 protein in mammalian cells is very low, the molecule has poor solubility at neutral pH, and intracellular proteolytic processing events result in a secreted BMP-7 having multiple amino-termini, creating a heterogeneous mixture of proteins. Utilizing structural information, we have designed and generated a number of rational BMP-7 mutations that improved both expression levels in mammalian cells and solubility at neutral pH, while limiting the amino-terminal heterogeneity of the mature protein. Introduction of these mutations did not compromise BMP-7 in vitro bioactivity. This improved BMP-7 molecule is better suited for pharmaceutical development and clinical advancement for indications where systemic delivery may be required.
Similar articles
-
Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli.Protein Expr Purif. 2006 Apr;46(2):374-8. doi: 10.1016/j.pep.2005.09.025. Epub 2005 Oct 27. Protein Expr Purif. 2006. PMID: 16298141
-
BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.Connect Tissue Res. 2006;47(5):271-7. doi: 10.1080/03008200600995908. Connect Tissue Res. 2006. PMID: 17118749
-
Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes.Int J Mol Med. 2007 Jul;20(1):53-7. Int J Mol Med. 2007. PMID: 17549388
-
Bone morphogenetic protein.Biochem Biophys Res Commun. 2007 Oct 26;362(3):550-3. doi: 10.1016/j.bbrc.2007.08.045. Epub 2007 Aug 20. Biochem Biophys Res Commun. 2007. PMID: 17719560 Review.
-
Improving bone morphogenetic protein (BMP) production in CHO cells through understanding of BMP synthesis, signaling and endocytosis.Biotechnol Adv. 2023 Jan-Feb;62:108080. doi: 10.1016/j.biotechadv.2022.108080. Epub 2022 Dec 13. Biotechnol Adv. 2023. PMID: 36526238 Review.
Cited by
-
The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases.Cells. 2020 Jan 23;9(2):280. doi: 10.3390/cells9020280. Cells. 2020. PMID: 31979268 Free PMC article. Review.
-
Molecular Validation of PACE4 as a _target in Prostate Cancer.Transl Oncol. 2011 Jun;4(3):157-72. doi: 10.1593/tlo.10295. Epub 2011 Jun 1. Transl Oncol. 2011. PMID: 21633671 Free PMC article.
-
Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease.Pediatr Nephrol. 2008 Sep;23(9):1395-8. doi: 10.1007/s00467-008-0818-x. Epub 2008 Apr 30. Pediatr Nephrol. 2008. PMID: 18446379
-
_targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.Oncogene. 2020 Jan;39(5):987-1003. doi: 10.1038/s41388-019-1047-4. Epub 2019 Oct 7. Oncogene. 2020. PMID: 31591478 Free PMC article.
-
Functional Characterization of Two New Variants in the Bone Morphogenetic Protein 7 Prodomain in Two Pairs of Monozygotic Twins With Hypospadias.J Endocr Soc. 2019 Feb 22;3(4):814-824. doi: 10.1210/js.2018-00333. eCollection 2019 Apr 1. J Endocr Soc. 2019. PMID: 30963139 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
